ETF Holdings Breakdown of SLNO

News associated with SLNO

Reviewing Soleno Therapeutics (NASDAQ:SLNO) & Guided Therapeutics (OTCMKTS:GTHP)

Soleno Therapeutics (NASDAQ:SLNO – Get Free Report) and Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends. Profitability This table compares Soleno Therapeutics and Guided […] - 2025-04-29 05:22:53

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Purchased by Legal & General Group Plc

Legal & General Group Plc grew its stake in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 9.2% during the 4th quarter, HoldingsChannel.com reports. The fund owned 23,471 shares of the company’s stock after purchasing an additional 1,983 shares during the quarter. Legal & General Group Plc’s holdings in Soleno Therapeutics were worth […] - 2025-04-28 07:56:52

Brokerages Set Soleno Therapeutics, Inc. (NASDAQ:SLNO) PT at $104.67

Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) has been assigned an average rating of “Buy” from the ten brokerages that are presently covering the company, MarketBeat Ratings reports. Eight analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 12 month price […] - 2025-04-28 05:39:09

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives $94.57 Consensus PT from Brokerages

Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) have been assigned an average recommendation of “Buy” from the nine ratings firms that are presently covering the company, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average […] - 2025-04-03 05:35:01

Soleno Therapeutics (NASDAQ:SLNO) Sees Strong Trading Volume Following Analyst Upgrade

Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) saw unusually-high trading volume on Monday after HC Wainwright raised their price target on the stock from $70.00 to $100.00. HC Wainwright currently has a buy rating on the stock. Approximately 891,497 shares traded hands during mid-day trading, an increase of 40% from the previous […] - 2025-04-01 05:54:47

Swiss National Bank Boosts Stock Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)

Swiss National Bank lifted its position in Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 27.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 45,900 shares of the company’s stock after purchasing an additional 9,900 shares during the quarter. Swiss National […] - 2025-03-28 08:28:50

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Consensus Rating of “Buy” from Brokerages

Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) have received an average recommendation of “Buy” from the seven ratings firms that are presently covering the firm, Marketbeat.com reports. Five analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average twelve-month target […] - 2025-03-06 07:21:27

Soleno Therapeutics (NASDAQ:SLNO) Earns “Buy” Rating from HC Wainwright

Soleno Therapeutics (NASDAQ:SLNO – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at HC Wainwright in a report issued on Monday,Benzinga reports. They presently have a $70.00 target price on the stock. HC Wainwright’s price objective would indicate a potential upside of 57.52% from the company’s previous close. A number of other […] - 2025-03-05 07:04:52

Allspring Global Investments Holdings LLC Decreases Stock Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)

Allspring Global Investments Holdings LLC trimmed its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 9.5% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 128,028 shares of the company’s stock after selling 13,396 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Soleno Therapeutics were worth $5,755,000 […] - 2025-02-20 08:24:48

Soleno Therapeutics (NASDAQ:SLNO) Upgraded at Lifesci Capital

Lifesci Capital upgraded shares of Soleno Therapeutics (NASDAQ:SLNO – Free Report) to a strong-buy rating in a research report report published on Tuesday morning,Zacks.com reports. Lifesci Capital also issued estimates for Soleno Therapeutics’ Q4 2024 earnings at ($0.37) EPS, Q1 2025 earnings at ($1.67) EPS, Q2 2025 earnings at ($1.13) EPS, Q3 2025 earnings at […] - 2025-02-07 08:36:55

SLNO institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-05-08	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	16,100	USD 1,227,786
2025-05-08	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	10,200	USD 777,852
2025-05-08	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	78	USD 5,948
Total =		26,378	USD 2,011,586

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer